A polymorphous rash of an uncommon blistering disease

Clin Exp Dermatol. 2018 Oct;43(7):839-842. doi: 10.1111/ced.13544. Epub 2018 May 10.

Authors

C H Tan¹, L Y Kuan², Y K Heng², J Y Pan², S I Tee², Y L Lim², L S Tan²

Affiliations

¹ Internal Medicine Department, Tan Tock Seng Hospital, Singapore, Singapore.
² Dermatology Department, National Skin Centre, Singapore, Singapore.

PMID: 29749071
DOI: 10.1111/ced.13544

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Anti-Bacterial Agents / adverse effects
Betamethasone / administration & dosage
Betamethasone / therapeutic use
Blister / chemically induced
Blister / drug therapy
Blister / pathology*
Diagnosis, Differential
Exanthema / chemically induced
Exanthema / pathology*
Glucocorticoids / therapeutic use
Humans
Immunoglobulin A / metabolism
Linear IgA Bullous Dermatosis / chemically induced
Linear IgA Bullous Dermatosis / diagnosis
Linear IgA Bullous Dermatosis / drug therapy
Linear IgA Bullous Dermatosis / pathology*
Male
Piperacillin, Tazobactam Drug Combination / adverse effects
Prednisolone / administration & dosage
Prednisolone / therapeutic use
Treatment Outcome
Vancomycin / adverse effects

Substances

Anti-Bacterial Agents
Glucocorticoids
Immunoglobulin A
Piperacillin, Tazobactam Drug Combination
Vancomycin
Betamethasone
Prednisolone